# Observational esophageal cancer studies: 112 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 112 trials that are observational for esophageal cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational esophageal cancer studies: 112 rows for $5.60, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/esophageal-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 112
- Recruiting or not yet: 112
- Read on: November 19, 2026

## Trials

The 25 newest of 112, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07939997 | ctDNA Observational Biomarker Validation Study for Evaluation of Esophageal Squamous Cell Carcinoma | University of Colorado, Denver | Observational | Not yet recruiting | Esophageal Squamous Cell Carcinoma (ESCC) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939997) |
| August 24, 2026 | NCT07780968 | Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA | Jazz Pharmaceuticals | Observational | Not yet recruiting | Esophageal Cancer, GastroEsophageal Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer, Stomach... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780968) |
| August 21, 2026 | NCT07778056 | Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation Study | Henan Cancer Hospital | Observational | Not yet recruiting | Esophageal Squamous Cell Carcinoma (ESCC) | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07778056) |
| August 20, 2026 | NCT07775859 | NOMAD-GI: Molecular-guided Non-operative Management and Organ Preservation Strategy After Precision Therapy in Gastrointestinal Cancers | Peking University Cancer Hospital & Institute | Observational | Not yet recruiting | Gastrointestinal Cancer, Gastric Cancer, Gastroesophageal Junction Cancer, Esophageal Cancer, Colorectal Cancer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775859) |
| August 11, 2026 | NCT07757022 | AI-Driven Digital Twin and Drug Simulation for Esophageal Cancer | Henan Cancer Hospital | Observational | Not yet recruiting | Esophageal Cancer | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07757022) |
| July 20, 2026 | NCT07714538 | Breath Research Narrow Validation for Gastrointestinal Cancer Detection | Imperial College London | Observational | Recruiting | Oesophageal Squamous Cell Carcinoma, Oesophageal Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Ductal... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07714538) |
| July 9, 2026 | NCT07691944 | Effect of VExUS Score on Postoperative Pulmonary Complications in Elderly Patients | First Affiliated Hospital of Chongqing Medical University | Observational | Not yet recruiting | Esophageal Cancer (EsC), Postoperative Pulmonary Complications (PPCs) | 126 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691944) |
| May 22, 2026 | NCT07605312 | AI-Based Risk Prediction Model for Upper Digestive Tract Cancer | National Taiwan University Hospital | Observational | Not yet recruiting | Gastric Cancer (GC), Premalignant Lesion, Gastric Intestinal Metaplasia, Atrophic Gastritis, Dysplasia Stomach... | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07605312) |
| May 19, 2026 | NCT07596654 | The Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer | Sponsor not shown (see the record) | Observational | Recruiting | Esophageal Carcinoma, Limited-Stage Small Cell Esophageal Carcinoma | 4 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07596654) |
| May 13, 2026 | NCT07584577 | Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in... | University Hospital, Bordeaux | Observational | Recruiting | Esophageal Cancer, Surgery Indication, Malnourished, Neoadjuvant Treatment | 670 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07584577) |
| May 7, 2026 | NCT07573397 | A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1... | Fudan University | Observational | Not yet recruiting | Esophageal Cancer | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07573397) |
| April 16, 2026 | NCT07533357 | Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal... | Fudan University | Observational | Not yet recruiting | Esophageal Cancer | 158 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07533357) |
| March 11, 2026 | NCT07464470 | Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers | Blokhin's Russian Cancer Research Center | Observational | Recruiting | Gastric Cancer, Esophageal Cancer, Brain Metastases | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07464470) |
| February 27, 2026 | NCT07440212 | Clinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112... | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Observational | Not yet recruiting | Esophagus Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07440212) |
| February 3, 2026 | NCT07382635 | Clinical Trial Protocol for Evaluating the Efficacy and Safety of Thoracoabdominal Endoscopic Surgery System in Remote Laparoscopic Surgery... | Sponsor not shown (see the record) | Observational | Not yet recruiting | Colorectal Cancer, Esophageal Cancer, Hepatectomy, Radical Hysterectomy | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07382635) |
| January 26, 2026 | NCT07365124 | MRinRT: Swansea University and SWWCC Collaboration Study. | Swansea Bay University Health Board | Observational | Not yet recruiting | Carcinoma, Glioblastoma, Radiotherapy, MRI, MRI-guided Adaptive Radiotherapy, MRI Scanner Configuration, MRI Image... | 165 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07365124) |
| January 21, 2026 | NCT07354295 | Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer （Radiogenomics-Esophagus） | Sponsor not shown (see the record) | Observational | Recruiting | Esophageal Cancer | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07354295) |
| January 7, 2026 | NCT07322627 | ALDH2 Single Nucleotide Polymorphisms and Prognosis of Esophageal Cancer Patients | National Taiwan University Hospital | Observational | Recruiting | Esophageal Cancer | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07322627) |
| December 31, 2025 | NCT07312526 | Shanghai Clinical Cohort - Esophageal Cancer | Shanghai Chest Hospital | Observational | Recruiting | Esophageal Cancer, Esophagectomy | 3,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07312526) |
| December 30, 2025 | NCT07309991 | Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy | Sun Yat-sen University | Observational | Recruiting | Esophageal Carcinoma, Esophageal Adenocarcinoma, Esophagectomy, PaO2, Esophageal Anastomotic Leakeage | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07309991) |
| December 24, 2025 | NCT07301814 | Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Observational | Recruiting | Gastric Cancer, Pancreatic Cancer, Cholangiocarcinoma Cancer, Esophageal Cancer | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07301814) |
| December 3, 2025 | NCT07260734 | AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2) | Imperial College London | Observational | Not yet recruiting | OESOPHAGO-GASTRIC CARCINOMA, Oesophageal Adenocarcinoma, Gastric Adenocarcinoma and Gastroesophageal Junction... | 6,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07260734) |
| October 2, 2025 | NCT07203690 | Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Imaging and Digital Pathology | Henan Cancer Hospital | Observational | Not yet recruiting | Esophageal Cancer, Neoadjuvant Therapy | 7,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07203690) |
| September 16, 2025 | NCT07176052 | Expectation, Pain Outcomes, and Pain Medication Following Oncology Abdominal Surgery: A Cohort Study | Copenhagen University Hospital, Rigshospitalet | Observational | Not yet recruiting | Cancer, Hepatic, Cancer, Esophagus, Cancer, Pancreas | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07176052) |
| September 10, 2025 | NCT07165210 | Incidence of 106TBL Lymph Node Metastasis | Fudan University | Observational | Recruiting | Esophageal Cancer | 1,852 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07165210) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Fudan University | 6 |
| Henan Cancer Hospital | 5 |
| University of Colorado, Denver | 4 |
| Imperial College London | 4 |
| University Medical Center Groningen | 4 |
| Sun Yat-sen University | 3 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| M.D. Anderson Cancer Center | 2 |
| University of Pittsburgh | 2 |
| Mayo Clinic | 2 |
| Launceston General Hospital | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 |
| National Taiwan University Hospital | 2 |
| University of Missouri-Columbia | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| University Hospital, Ghent | 1 |
| City of Hope Medical Center | 1 |
| Peking University | 1 |
| Ludwig-Maximilians - University of Munich | 1 |
| Paradigm Health | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Renmin Hospital of Wuhan University | 1 |
| Johns Hopkins University | 1 |
| Beijing Geekgene Technology Co., LTD | 1 |
| Heinrich-Heine University, Duesseldorf | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 32 |
| China | 27 |
| United Kingdom | 9 |
| Netherlands | 9 |
| Germany | 8 |
| Australia | 4 |
| Italy | 4 |
| Belgium | 3 |
| Canada | 3 |
| France | 3 |
| Spain | 3 |
| Japan | 2 |
| Taiwan | 2 |
| Sweden | 2 |
| Hungary | 1 |
| Russia | 1 |
| Kenya | 1 |
| Malawi | 1 |
| Tanzania | 1 |
| South Korea | 1 |
| Israel | 1 |
| Switzerland | 1 |
| Romania | 1 |
| Puerto Rico | 1 |
| Czechia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Contractors in the United States](https://specstream.ai/data/businesses/contractors/united-states)
- [Private equity firms in the United States](https://specstream.ai/data/businesses/private-equity-firms/united-states)
- [Contract law firms in the United States](https://specstream.ai/data/businesses/contract-law-firms/united-states)
- [Printing equipment suppliers in the United States](https://specstream.ai/data/businesses/printing-equipment-suppliers/united-states)
- [Construction management firms in the United States](https://specstream.ai/data/businesses/construction-management-firms/united-states)
- [Printing companies in the United States](https://specstream.ai/data/businesses/printing-companies/united-states)
